Life Science Nation - Connecting Products, Services & Capital

LSN INVESTOR DATABASE

Present and future-looking investor data is collected and curated by LSN’s Investor Research team through ongoing dialogue with 10,000 life science investors from around the world, identifying their investment mandates.

Learn More

LSN BUSINESS DEVELOPMENT DATABASE

The LSN business development database is the premier life science company database, covering over 100,000 companies around the world, with a particular focus on the bottom third of the market that is missed by traditional data providers.

Learn More

RESI CONFERENCE

Redefining Early Stage Investments is an ongoing conference series establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding.

Learn More

The Life Science Executive's Fundraising Manifesto

Raising capital is not a one-time event. It must be an ongoing part of your business strategy. The book reveals the expertise required to continually fundraise and bring your ideas to market.

Learn More

Life Science Nation (LSN) is a global partnering ecosystem that allows early-stage companies with compelling technology assets to get plugged into the early-stage investor and channel partner’s radars with minimal cost and a big ROI. LSN is a global matching platform for early-stage buyers and sellers across the domains of Drugs, Devices, Diagnostics and Digital Health – the “4 Ds”. LSN curates two databases: a buy-side of global cross-border early-stage investors/partners and a sell-side of global cross-domain technology assets. LSN also offers a sourcing and ranking service for clients who need to source and rank technology assets for channel, pipeline and portfolio development. LSN owns and operates the Redefining Early Stage Investments (RESI) conference series, a funding superstructure that runs five times a year during J.P. Morgan in San Francisco (January), alongside BIO Europe (March), alongside BIO U.S (June), Boston (September) and Asia in Shanghai and Taipei (November). LSN also owns and operates the Focus on Cures Accelerator (FOC) that provides international startups a Boston-based footprint and helps them develop and execute a global investor and channel partner strategy.